AMGN

Amgen
D

AMGN

Arincen67/100B

Amgen net income 1985–2026

Amgen earned 3.86B USD in Q3 FY2026, the three months to 30 September 2026, up 20.1% on the same quarter a year before. Amgen's net income over the last twelve months was 9.39B USD, up 34.1% on the twelve months before. In fiscal year 2025 it earned 7.71B USD, up 88.5% on the year before.

Last updated 12 Nov 2026 · Next report 2 Feb 2027

Net income

Net income · +1.1% a year over 10 yearsNet margin

Growth

Fiscal yearPeriod endingNet incomeGrowthNet marginRevenue
TTM30 Sept 20269.39B+34.06%24.12%38.93B
FY202531 Dec 20257.71B+88.53%20.99%36.74B
FY202431 Dec 20244.09B-39.11%12.24%33.42B
FY202331 Dec 20236.72B+2.52%23.83%28.19B
FY202231 Dec 20226.55B+11.18%24.89%26.32B
FY202131 Dec 20215.89B-18.87%22.68%25.98B
FY202031 Dec 20207.26B-7.37%28.57%25.42B
FY201931 Dec 20197.84B-6.58%33.57%23.36B
FY201831 Dec 20188.39B+324.15%35.35%23.75B
FY201731 Dec 20171.98B-74.37%8.66%22.85B
FY201631 Dec 20167.72B+11.28%33.59%22.99B
FY201531 Dec 20156.94B+34.53%32.03%21.66B
FY201431 Dec 20145.16B+1.52%25.71%20.06B
FY201331 Dec 20135.08B+16.94%27.21%18.68B
FY201231 Dec 20124.35B+17.97%25.17%17.27B
FY201131 Dec 20113.68B-20.40%23.64%15.58B
FY201031 Dec 20104.63B+0.48%30.74%15.05B
FY200931 Dec 20094.61B+9.75%31.45%14.64B
FY200831 Dec 20084.20B+32.53%27.97%15.00B
FY200731 Dec 20073.17B+7.32%21.43%14.77B
FY200631 Dec 20062.95B-19.71%20.68%14.27B
FY200531 Dec 20053.67B+55.48%29.56%12.43B
FY200431 Dec 20042.36B+4.58%22.40%10.55B
FY200331 Dec 20032.26B—27.04%8.36B
FY200231 Dec 2002-1.39B-224.31%-25.20%5.52B
FY200131 Dec 20011.12B-1.65%27.88%4.02B
FY200031 Dec 20001.14B+3.84%33.02%3.45B
FY199931 Dec 19991.10B+27.02%34.22%3.20B
FY199831 Dec 1998863.20M+33.97%32.67%2.64B
FY199731 Dec 1997644.30M-5.22%27.47%2.35B
FY199631 Dec 1996679.80M+26.43%30.93%2.20B
FY199531 Dec 1995537.70M+68.19%28.24%1.90B
FY199431 Dec 1994319.70M-16.59%19.73%1.62B
FY199331 Dec 1993383.30M+7.19%28.29%1.35B
FY199231 Dec 1992357.60M+265.27%33.10%1.08B
FY199131 Dec 199197.90M+412.57%14.40%679.80M
FY199031 Dec 199019.10M—10.03%190.40M
FY198831 Dec 1988-8.20M-582.35%-11.68%70.20M
FY198731 Dec 19871.70M+112.50%3.84%44.30M
FY198631 Dec 1986800.00K+60.00%2.68%29.80M
FY198531 Dec 1985500.00K—2.37%21.10M

Figures in USD. Shares and EPS are adjusted for stock splits. Quarterly growth is on the same quarter a year before; TTM is the last four quarters.

See also:Revenue,EPS,Shares outstanding,Operating income,Cash on hand,Total debt,Free cash flow,Stock buybacks,Income statement

Common questions about Amgen's profit

Source: Financial Modeling PrepVerified against SEC filings